CRISPR Therapeutics AG
(NASDAQ : CRSP)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Biotechnology
symbolcompany%chnglast%shortavg$volume
AMGNAmgen Inc.
0.41%198.201.2%$509.37m
GILDGilead Sciences, Inc.
0.11%73.670.9%$447.54m
BIIBBiogen Inc.
0.15%331.451.3%$369.16m
CELGCelgene Corporation
0.10%82.661.2%$330.77m
ILMNIllumina, Inc.
-1.09%318.193.5%$287.29m
REGNRegeneron Pharmaceuticals, Inc.
-1.03%380.192.6%$221.63m
ALXNAlexion Pharmaceuticals, Inc.
0.79%122.902.0%$210.39m
VRTXVertex Pharmaceuticals Incorporated
-0.74%179.981.9%$201.98m
SRPTSarepta Therapeutics, Inc.
2.45%133.7016.4%$170.50m
AAgilent Technologies, Inc.
-0.08%66.191.5%$154.43m
BMRNBioMarin Pharmaceutical Inc.
0.94%100.444.4%$129.55m
VKTXViking Therapeutics, Inc.
-1.04%14.310.9%$107.63m
LGNDLigand Pharmaceuticals Incorporated
-1.28%200.0023.3%$106.76m
NKTRNektar Therapeutics
1.13%49.465.6%$106.65m
NBIXNeurocrine Biosciences, Inc.
-0.24%111.215.1%$96.74m

Company Profile

CRISPR Therapeutics AG engages in the development and commercializtion of therapies derived from genome-editing technology. Its proprietary platform CRISPR/Cas9-based therapeutics allows for precise and directed changes to genomic DNA. The company was founded by Rodger Novak, Emmanuelle Charpentier, and Shaun Patrick Foy in 2014 and is headquartered in Zug, Switzerland.